Daniel J. Hicklin
Impact in
- Cancer Research top 0.05%
- Cancer, Hypoxia, and Metabolism
- Oncology top 0.05%
- Lymphatic System and Diseases
- Cancer Cells and Metastasis
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
- Oncology 87
- Vascular Tumors and Angiosarcomas 20
- HER2/EGFR in Cancer Research 16
- Lymphatic System and Diseases 15
-
- Cancer, Hypoxia, and Metabolism 44
- Co-authors
- Lee M. EllisLarry WittePeter BöhlenZhenping ZhuRobert S. KerbelShahin RafiiMalcolm A.S. MooreShan Man
- Journals
- Cancer Research (28 papers)Clinical Cancer Research (12 papers)Blood (11 papers)Journal of Clinical Investigation (7 papers)Cancer (6 papers)
- Partner nations
- United StatesCanadaJapan
In The Last Decade
Daniel J. Hicklin
183 papers receiving 34.4k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 8.8k
- Oncology 14.0k
- Molecular Biology 20.8k
- Genetics 3.2k
- Immunology and Allergy 1.6k
Countries citing papers authored by Daniel J. Hicklin
This map shows the geographic impact of Daniel J. Hicklin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. Hicklin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. Hicklin more than expected).
Fields of papers citing papers by Daniel J. Hicklin
This network shows the impact of papers produced by Daniel J. Hicklin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. Hicklin. The network helps show where Daniel J. Hicklin may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel J. Hicklin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2023 | 8 | |
| 3 | 2010 | 17 | |
| 4 | Tumor bed irradiation enhances sensitivity of A431 tumor xenografts to C225 anti-EGFR antibody | 2008 | 1 |
| 5 | 2007 | 184 | |
| 6 | IMC-A12 enhances the efficacy of cetuximab + gemcitabine therapy in human pancreatic carcinoma xenografts. | 2007 | 3 |
| 7 | 2006 | 105 | |
| 8 | 2006 | 126 | |
| 9 | mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt Hit paper breakdown → | 2006 | 2037 |
| 10 | 2006 | 127 | |
| 11 | 2005 | 470 | |
| 12 | Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation Hit paper breakdown → | 2004 | 976 |
| 13 | Expression and function of vascular endothelial growth factor receptor–1 in human colon cancer cells | 2004 | 1 |
| 14 | Antitumor activity of a novel, human anti-epidermal growth factor receptor (EGFR) monoclonal antibody (IMC-11F8) in human tumor xenograft models | 2004 | 13 |
| 15 | 2003 | 59 | |
| 16 | Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability. | 2002 | 86 |
| 17 | 2000 | 8 | |
| 18 | 2000 | 139 | |
| 19 | Monoclonal antibody to vascular endothelial-cadherin is a potent inhibitor of angiogenesis, tumor growth, and metastasis. | 2000 | 99 |
| 20 | 1998 | 12 |
About Daniel J. Hicklin
Daniel J. Hicklin is a scholar working on Oncology, Cancer Research, Immunology and Allergy, Molecular Biology and Genetics, having authored 185 papers that have together received 35.4k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (102 papers), Cancer, Hypoxia, and Metabolism (44 papers), Monoclonal and Polyclonal Antibodies Research (22 papers), Vascular Tumors and Angiosarcomas (20 papers), HER2/EGFR in Cancer Research (16 papers), Lymphatic System and Diseases (15 papers), Immunotherapy and Immune Responses (14 papers) and Cell Adhesion Molecules Research (12 papers). The work is most often cited by research in Cancer Research (8.8k citations), Oncology (14.0k citations), Molecular Biology (20.8k citations), Genetics (3.2k citations) and Immunology and Allergy (1.6k citations). Daniel J. Hicklin has collaborated with scholars based in United States, Canada and Japan. Frequent co-authors include Lee M. Ellis, Larry Witte, Peter Böhlen, Zhenping Zhu, Robert S. Kerbel, Shahin Rafii, Malcolm A.S. Moore, Shan Man, Francesco M. Marincola and Gabriele Bergers. Their work appears in journals such as Cancer Research, Clinical Cancer Research, Blood, Journal of Clinical Investigation and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.